Literature DB >> 9794554

Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis.

Y Horita1, M Miyazaki, T Koji, N Kobayashi, M Shibuya, M S Razzaque, M Cheng, Y Ozono, S Kohno, T Taguchi.   

Abstract

BACKGROUND: Based on the fact that vascular endothelial growth factor (VEGF) increases vascular permeability, it is speculated that VEGF might be involved in the development of proteinuria, although this remains unconfirmed. The production and site of action of VEGF remains unclear in nephrotic renal diseases.
METHODS: Non-radioactive in situ hybridization was performed to examine the expression of VEGF mRNA and its receptors, flt-1 and KDR/flk-1, in a rat model of nephrosis induced by intraperitoneal injection of bovine serum albumin (BSA). Saline injected rats were served as control animals.
RESULTS: Neither morphological changes nor deposition of immunoglobulin or complement were observed in our model. Proteinuria developed, reaching a maximum level in rats injected with BSA for 3 days, followed by persistent proteinuria until day 14. The expression of mRNA for VEGF and the two receptors was markedly upregulated in glomeruli of BSA-induced nephritis compared with the control group. VEGF mRNA was localized in glomerular cells, including cells in mesangium, visceral and parietal epithelial cells. In contrast, flt-1 mRNA and KDR/flk-1 mRNA were expressed on glomerular endothelial cells and cells in mesangium. The ratio of glomerular cells positive for VEGF mRNA and its receptors mRNA increased proportionately with the severity of proteinuria. Immunohistochemistry for ED-1 and proliferating cell nuclear antigen showed no significant increase in infiltrating macrophage or cellular proliferation.
CONCLUSIONS: Our results suggest that altered glomerular expression of VEGF and its receptors is not associated with proliferation of endothelial cells, but rather with proteinuria in BSA-induced nephritis in rats. VEGF may play a different role in different renal diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794554     DOI: 10.1093/ndt/13.10.2519

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

Review 1.  Genetics of childhood steroid-sensitive nephrotic syndrome.

Authors:  Alana M Karp; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2016-07-29       Impact factor: 3.714

2.  Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats.

Authors:  Paul F Laflam; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2005-10-07       Impact factor: 3.714

3.  Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis.

Authors:  Franziska Theilig; Anne Kathrin Enke; Brigitte Scolari; Danny Polzin; Sebastian Bachmann; Robert Koesters
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

4.  Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

Authors:  Y Masuda; A Shimizu; T Mori; T Ishiwata; H Kitamura; R Ohashi; M Ishizaki; G Asano; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  Effects of Huanshuai Recipe Oral Liquid on restructuring glomerular microvasculature and expression of vascular endothelial growth factor in subtotal nephrectomized rats.

Authors:  Shen Li; Xiang-rong Rao; Jin-ye Song; Li-qiang Meng; Lei Qu; Xiao-mei Li
Journal:  Chin J Integr Med       Date:  2010-08-08       Impact factor: 1.978

6.  Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli.

Authors:  Andrew H J Salmon; Christopher R Neal; David O Bates; Steven J Harper
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

7.  Relevance of VEGF and nephrin expression in glomerular diseases.

Authors:  Claudia A Bertuccio
Journal:  J Signal Transduct       Date:  2011-07-26

8.  The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.

Authors:  Jung Nam An; Jin Ho Hwang; Jung Pyo Lee; Ho Jun Chin; Sejoong Kim; Dong Ki Kim; Suhnggwon Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

9.  Understanding the mechanisms of proteinuria: therapeutic implications.

Authors:  Jorge E Toblli; P Bevione; F Di Gennaro; L Madalena; G Cao; M Angerosa
Journal:  Int J Nephrol       Date:  2012-07-04

10.  Beneficial effects of thiazolidinediones on diabetic nephropathy in OLETF rats.

Authors:  Mi Young Lee; Eun Young Lee; Byung Jun Lee; Chan Sik Won; Jang Hyun Koh; Jang Yel Shin; Young Goo Shin; Byung Pil Cho; Choon Hee Chung
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.